ArticleTherapeutic advances in medical oncology2025

Efficacy and safety of a novel treatment scheme of RC48-ADC plus PD-1 inhibitors in metastatic urothelial carcinoma: a multicenter real-world study.

Jun Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.